FDA Approved: BUCAPSOL — Supplemental Application (PANGEA PHARMACEUTICALS, LLC)

View source ↗

Summary

The FDA approved a supplemental application for BUCAPSOL (buspirone hydrochloride) from PANGEA PHARMACEUTICALS, LLC, under an ANDA supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• BUCAPSOL (buspirone hydrochloride)

Snippet

SUPPL AP for BUCAPSOL (BUSPIRONE HYDROCHLORIDE)